Skip to content

ORIC PHARMACEUTICALS, INC.

ORIC

CIK 0001796280

← back to feed
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$134.73M
−1.3% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.56
+19.7% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$116.7M
Q1 Apr 2026
Cash
$56.4M
Q1 Apr 2026
Total Debt
$10.5M
Q1 Apr 2026
Shares Outstanding
103.52M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings